[Alpha Tau in PR Newswire] Alpha Tau announces new research collaboration to study the potential of Alpha DaRT to enhance immune stimulation in the treatment of breast cancer

Alpha Tau Medical Ltd. (“Alpha Tau”), the developer of the innovative alpha-radiation cancer therapy Alpha DaRT™, announced today that it has signed a sponsored research agreement with investigators at The University of Texas MD Anderson Cancer Center (“MD Anderson”) to evaluate potential immune stimulation by combining Alpha DaRT™ with DNA-repair inhibitors and immune checkpoint inhibitors for the treatment of breast tumors.

Read more here.

Source: https://blog.ourcrowd.com/alpha-tau-announces-new-research-collaboration-to-study-the-potential-of-alpha-dart-to-enhance-immune-stimulation-in-the-treatment-of-breast-cancer/